Chugai Pharma Taiwan convened its board of directors meeting in December of 2024, during which all board members unanimously resolved to appoint Mr. Yuji Habara as the new President, effective January 1st of 2025.
With extensive management experience and profound expertise in the pharmaceutical and biotechnology industries, President Yuji Habara is expected to lead Chugai Pharma Taiwan toward continued steady progress in achieving the group's vision. Under his leadership, the company will not only bring innovative products to patients but also actively contribute to society, safeguard human health and well-being, and strive for excellence.
